Advent Private Equity Fund Iii B Ltd Partnership - Net Worth and Insider Trading
Advent Private Equity Fund Iii B Ltd Partnership Net Worth
The estimated net worth of Advent Private Equity Fund Iii B Ltd Partnership is at least $2 Million dollars as of 2024-11-07. Advent Private Equity Fund Iii B Ltd Partnership is the Member of 13(d) Group of Emergent BioSolutions Inc and owns about 229,497 shares of Emergent BioSolutions Inc (EBS) stock worth over $2 Million. Details can be seen in Advent Private Equity Fund Iii B Ltd Partnership's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Advent Private Equity Fund Iii B Ltd Partnership has not made any transactions after 2007-03-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Advent Private Equity Fund Iii B Ltd Partnership
Advent Private Equity Fund Iii B Ltd Partnership Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Advent Private Equity Fund Iii B Ltd Partnership owns 1 companies in total, including Emergent BioSolutions Inc (EBS) .
Insider Ownership Summary of Advent Private Equity Fund Iii B Ltd Partnership
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EBS | Emergent BioSolutions Inc | 2007-03-08 | other: Member of 13(d) Group |
Advent Private Equity Fund Iii B Ltd Partnership Latest Holdings Summary
Advent Private Equity Fund Iii B Ltd Partnership currently owns a total of 1 stock. Advent Private Equity Fund Iii B Ltd Partnership owns 229,497 shares of Emergent BioSolutions Inc (EBS) as of March 8, 2007, with a value of $2 Million.
Latest Holdings of Advent Private Equity Fund Iii B Ltd Partnership
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EBS | Emergent BioSolutions Inc | 2007-03-08 | 229,497 | 9.20 | 2,111,372 |
Holding Weightings of Advent Private Equity Fund Iii B Ltd Partnership
Advent Private Equity Fund Iii B Ltd Partnership Form 4 Trading Tracker
According to the SEC Form 4 filings, Advent Private Equity Fund Iii B Ltd Partnership has made a total of 0 transactions in Emergent BioSolutions Inc (EBS) over the past 5 years. The most-recent trade in Emergent BioSolutions Inc is the sale of 0 shares on March 8, 2007, which brought Advent Private Equity Fund Iii B Ltd Partnership around $0.
Insider Trading History of Advent Private Equity Fund Iii B Ltd Partnership
- 1
Advent Private Equity Fund Iii B Ltd Partnership Trading Performance
Advent Private Equity Fund Iii B Ltd Partnership Ownership Network
Ownership Network List of Advent Private Equity Fund Iii B Ltd Partnership
Ownership Network Relation of Advent Private Equity Fund Iii B Ltd Partnership
Advent Private Equity Fund Iii B Ltd Partnership Owned Company Details
What does Emergent BioSolutions Inc do?
Who are the key executives at Emergent BioSolutions Inc?
Advent Private Equity Fund Iii B Ltd Partnership is the other: Member of 13(d) Group of Emergent BioSolutions Inc. Other key executives at Emergent BioSolutions Inc include SVP & Bioservices William Hartzel , Interim CEO Miller H Haywood Iii , and SVP & Products Business Paul Anthony Williams .
Emergent BioSolutions Inc (EBS) Insider Trades Summary
Over the past 18 months, Advent Private Equity Fund Iii B Ltd Partnership made no insider transaction in Emergent BioSolutions Inc (EBS). Other recent insider transactions involving Emergent BioSolutions Inc (EBS) include a net sale of 16,449 shares made by Kathryn C Zoon ,
In summary, during the past 3 months, insiders sold 0 shares of Emergent BioSolutions Inc (EBS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 16,449 shares of Emergent BioSolutions Inc (EBS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 16,449 shares.
Emergent BioSolutions Inc (EBS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Emergent BioSolutions Inc Insider Transactions
Advent Private Equity Fund Iii B Ltd Partnership Mailing Address
Above is the net worth, insider trading, and ownership report for Advent Private Equity Fund Iii B Ltd Partnership. You might contact Advent Private Equity Fund Iii B Ltd Partnership via mailing address: 25 Buckingham Gate, London England X0 0000000000.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
